Hologic, Inc. (HOLX) Given Buy Rating at BTIG Research

Hologic, Inc. (HOLX) Given Buy Rating at BTIG Research


's stock had its "buy" rating reiterated by BTIG Research in a research report issued on Sunday. They currently have a $47.00 price target on the stock.



from Biotech News